Identification of Patients at High Risk For Opioid-induced Respiratory Depression
Tuesday, December 17, 2019
1 PM EST/12 PM CST
Presented by Carla R. Jungquist, PhD, ANP-BC, FAAN, Associate Professor, University at Buffalo School of Nursing
The objective of the presentation is to provide evidence on how best to screen for patients that may experience opioid induced respiratory depression.
Primary Audience: Nurses who care for patients taking opioids either in inpatient or outpatient settings.
The goals of this presentation are:
- Establish incidence of adverse events related to opioid induced respiratory depression
- Discuss evidence based tools for screening patient’s risk for OIRD
- Report on ASPMN® Guidelines for Monitoring Hospitalized Patients for Advancing Sedation and Respiratory Depression
- Participants will demonstrate knowledge of the incidence of OIRD
- Participants will demonstrate knowledge of tools used to screen for risk of OIRD
- Participants will demonstrate knowledge of best practices for monitoring hospitalized patients for OIRD
Funding for this initiative was made possible by an educational grant from:
Carla R. Jungquist has declared the following conflict of interest: Primary Investigator of the PRODIGY Medtronic funded study. Salary support.
The Greater Kansas City Chapter of the American Society for Pain Management Nursing® is approved as a provider of continuing nursing education by the Kansas State Board of Nursing. This course offering has been submitted for approval for nursing contact hours applicable for RN, LPN and LMHT relicensure.